TABLE 1.
Pharmacokinetic Parameters
| Subject | Age (days) | Serum Creatinine |
Clearance (mL/kg/h) |
Vd (mL/kg) | Half life (h) |
Kel (h−1) |
AUC0–24 (mg*hr/L) |
|---|---|---|---|---|---|---|---|
| 1 | 6 | 1.0 | 27 | 785 | 19.9 | 0.050 | 493 |
| 2 | 13 | 1.3 | 14 | 1441 | 73.4 | 0.013 | 350 |
| 3 | 14 | 0.8 | 12 | 1522 | 91.4 | 0.010 | 338* |
| 4 | 14 | 0.5 | 18 | 1021 | 39.1 | 0.025 | 466 |
| 5 | 19 | 1.2 | 9 | 1081 | 79.4 | 0.012 | 493 |
| 6 | 36 | 0.5 | 21 | 711 | 23.8 | 0.042 | 598 |
| 7 | 55 | 0.3 | 23 | 882 | 27.2 | 0.036 | 506 |
| 8 | 59 | 0.2 | 14 | 1635 | 81.2 | 0.012 | 271 |
| Median | 17 | 0.7 | 16 | 1051 | 56 | 0.02 | 479 |
| (IQR) | (14–41) | (0.4–1.1) | (13–21) | (858–1461) | (26–80) | (0.01–0.03) | (347–496) |
Infant 3 was supported by extracorporeal membrane oxygenation.